mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells. by Grahammer, Florian et al.
BASIC RESEARCH www.jasn.org
mTOR Regulates Endocytosis and Nutrient Transport
in Proximal Tubular Cells
Florian Grahammer,* Suresh K. Ramakrishnan,† Markus M. Rinschen,‡ Alexey A. Larionov,†
Maryam Syed,† Hazim Khatib,§ Malte Roerden,§ Jörn Oliver Sass,|¶ Martin Helmstaedter,*
Dorothea Osenberg,* Lucas Kühne,* Oliver Kretz,* Nicola Wanner,* Francois Jouret,**
Thomas Benzing,‡ Ferruh Artunc,§ Tobias B. Huber,*††‡‡ and Franziska Theilig†
*Department of Medicine IV, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg,
Freiburg, Germany; †Institute of Anatomy, Department of Medicine, University of Fribourg, Fribourg, Switzerland;
‡Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne,
Germany; §Department of Medical IV, Sektion Nieren- und Hochdruckkrankheiten, University of Tübingen, Tübingen,
Germany; |Bioanalytics and Biochemistry, Department of Natural Sciences, Bonn Rhein Sieg University of Applied
Sciences, Rheinbach, Germany; ¶Division of Clinical Chemistry and Biochemistry and Children’s Research Centre,
University Children’s Hospital Zürich, Zurich, Switzerland; **Groupe Interdisciplinaire de Génoprotéomique Appliquée,
Cardiovascular Sciences, University of Liège, Liege, Belgium; and ††BIOSS, Centre for Biological Signalling Studies and
‡‡FRIAS, Freiburg Institute for Advanced Studies and ZBSA, Center for Biological System Analysis, Albert Ludwigs
University of Freiburg, Freiburg, Germany
ABSTRACT
Renal proximal tubular cells constantly recycle nutrients to ensure minimal loss of vital substrates into the
urine. Althoughmost of the transportmechanisms have been discovered at themolecular level, little is known
about the factors regulating these processes. Here, we show that mTORC1 and mTORC2 speciﬁcally and
synergistically regulate PTC endocytosis and transport processes. Using a conditional mouse genetic ap-
proach to disable nonredundant subunits of mTORC1, mTORC2, or both, we showed that mice lacking
mTORC1 or mTORC1/mTORC2 but not mTORC2 alone develop a Fanconi-like syndrome of glucosuria,
phosphaturia, aminoaciduria, low molecular weight proteinuria, and albuminuria. Interestingly, proteomics
and phosphoproteomics of freshly isolated kidney cortex identiﬁed either reduced expression or loss of
phosphorylation at critical residues of different classes of speciﬁc transport proteins. Functionally, this resul-
ted in reduced nutrient transport and a profoundperturbation of the endocyticmachinery, despite preserved
absolute expression of themain scavenger receptors, MEGALIN and CUBILIN. Our ﬁndings highlight a novel
mTOR–dependent regulatory network for nutrient transport in renal proximal tubular cells.
J Am Soc Nephrol 28: ccc–ccc, 2016. doi: 10.1681/ASN.2015111224
With the transition fromwater to land, mammalian
kidneys developed into a high–pressure ﬁltration
system combining excess ultraﬁltration with highly
efﬁcient tubular reabsorption to minimize nutrient
and protein loss.1 The vast amount of the ultraﬁl-
trate (approximately 60%–70%), including virtu-
ally all nutrients, is already being reabsorbed by the
ﬁrst nephron segment, the proximal tubule (PT).2
Speciﬁc loss of PT amino acid or phosphate trans-
port function is associated with genetically deﬁned
disease entities, such as Hartnup disorder or hypo-
phosphatemic rickets.3,4 In contrast, disrupted en-
ergy metabolism or toxic injury can simultaneously
affect several transport systems, leading to a Fanconi
syndrome.5,6 In addition to aminoaciduria,
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glucosuria, and phosphaturia, Fanconi syndrome is charac-
terized by low molecular weight proteinuria.7 This is caused
by dysfunction of receptor-mediated endocytosis, which is
mediated by the two scavenger receptors, MEGALIN and
CUBILIN, followed by clathrin-mediated internalization of
the ligand-receptor complex.8 Fusion with early endosomes
delivers the complex to the endosomal-lysosomal com-
partment, leading to recycling or degradation of retrieved
proteins.8 The prominent endocytotic activity of the PT is
important to retrieve vital plasma proteins and maintain
body homeostasis.9 Although individual components of this
system have been recently described, little is known on the
organ-speciﬁc regulation of these transport processes.
The mammalian homolog of TOR1 (mTORC1) and
mTORC2 are intracellular multiprotein complexes regulating
tissue–speciﬁc cellular functions.10 The regulatory associated
protein of mammalian target of rapamycin (RAPTOR) is im-
portant to assemble mammalian target of rapamycin (mTOR)
complex 1, and its function can be blocked by rapamycin. In
contrast, mTORC2, containing the rapamycin-insensitive
companion of mammalian target of rapamycin (RICTOR)
as a scaffolding protein, seems to be insensitive to short–
term rapamycin treatment.11 mTORC1 integrates a wide va-
riety of signals, including growth factors, amino acids, cellular
energy content, and cellular stress, to regulate cellular growth
and division as well as lipid andmitochondrial biogenesis.12,13
The wide range of mTORC1 phosphorylation targets is still
incompletely deﬁned but seems to vary in a cell-speciﬁc man-
ner. Conversely, mTORC2 seems to be activated by insulin and
related pathways and controls several downstream AGC ki-
nases by phosphorylating their hydrophobic motif.14,15
Thereby, mTORC2 could play an important role in cell sur-
vival and organization of the cytoskeleton.
To investigate the effect of mTOR-controlled signaling in PT
function, we generated inducible conditional Raptor, Rictor, or
double-knockoutmice in renal tubular cells along the nephron.
RESULTS
Loss of mTOR in PT Cells Results in a Fanconi-Like
Phenotype
Expression of themTORC1 andmTORC2 complexes in the PT
was veriﬁed by staining for mTOR, RAPTOR, S6K1, ribosomal
S6 protein (S6P), and N-Myc Downstream Regulated 1
(NDRG1) (Supplemental Figure 1). All components were
strongly expressed in the S1 and S2 segments of the PT in either
overlay or close vicinity toMEGALIN. The proximal tubular S3
segment only showed minor signal intensity for mTOR, S6K1,
and S6P and was devoid of signals for RAPTOR and NDRG1.
To examine the effects of mTORC deletion on PT function, we
generated mice with doxycycline–inducible Pax8 promotor–
driven tubular deletion of Raptor (Raptorﬂ/ﬂ 3 Pax8rtTA 3
TetOCre; subsequently termed RapDTubule), Rictor (Rictorﬂ/ﬂ 3
Pax8rtTA 3 TetOCre; subsequently termed RicDTubule), or both
genes (Raptorﬂ/ﬂ 3 Rictorﬂ/ﬂ 3 Pax8rtTA 3 TetOCre; subse-
quently termed RapRicDTubule) (Figure 1, A–C). Protein abun-
dance or reduced phosphorylation of known downstream targets
was used to assess efﬁciency of our knockout approach (Figure 1,
D–F). In comparisonwith the respective control group, all exam-
ined parameters were at least reduced by 70% (RapDTubule:
RAPTOR, 274.6%64.6%; p-S6P/S6P, 278.9%66.4%; P,0.05;
n=6; RicDTubule: RICTOR, 284.5%68.4%; p-NDRG1/
NDRG1,271.1%63.7%; P,0.05; n=6; RapRicDTubule: RAPTOR,
278.3%66.2%; RICTOR, 269.1%65.3%; p-S6P/S6P, 289.2%
64.7%; p-NDRG1/NDRG1,271.7%69.8%; P,0.05; n=6) (Fig-
ure 1, D–F).
Measurement of urinary glucose and phosphate excretion
in RapRicDTubule mice revealed 3.3- and ﬁvefold increases in
urinary losses of glucose and phosphate, respectively, in-
dicating impaired nutrient reabsorption (Figure 1H). In
addition, SDS-PAGE of urinary samples revealed a slight
increase in albuminuria in RapDTubule, which was signiﬁcant
in RapRicDTubule (Figure 1, I and K). This observation was
conﬁrmed by direct measurement of mouse albumin in uri-
nary samples (Figure 1L). Furthermore, an increase in low
molecular mass (LMW) proteinuria between 25 and 68 kD
could be detected in RapRicDTubule (+126%637%; P,0.05;
n=5) as well as a signiﬁcant increase in proteinuria at ap-
proximately 25 kD in RapDTubule and RapRicDTubule animals
(RapDTubule: +70%613%; RapRicDTubule: +44%66%;
P,0.05; n=5). In addition, a pronounced increase in urinary
amino acid excretion was observed in RapDTubule animals, and
an even more pronounced increase was in RapRicDTubule an-
imals but not in RicDTubule mice (Figure 1M, Supplemental
Figure 2A). Amino acid plasma concentrations were similar
in all experimental groups (Supplemental Figure 2B),
conﬁrming a renal amino acid transport defect rather than
defects in hepatic or muscular metabolism.
Compared with control mice, RapDTubule and RapRicDTubule
animals showed signiﬁcantly higher food and ﬂuid intakes,
which were associated with increased urinary volume and
sodium excretion (Supplemental Table 1). No alterations
were found in RicDTubule animals. Together, these data
show a signiﬁcant mTORC1–dependent defect in tubular
reabsorption of glucose, phosphate, amino acids, LMW pro-
teins, and albumin.
mTOR Regulates PTC Endocytosis and Intracellular
Trafﬁcking In Vivo
To gain additional insights into the effects of gene knockout on
PT endocytosis, mice were injected with horseradish perox-
idase (taken up by ﬂuid-phase endocytosis) and Alexa555-
coupled lactoglobulin (reabsorbed by receptor-mediated
endocytosis) before perfusion ﬁxation.16 Morphologic anal-
ysis revealed a strong reduction of ﬂuid-phase endocytosis in
RapDTubule and RapRicDTubule animals, whereas no change was
observed in RicDTubule mice (Figure 2A). Similarly, confocal
microscopy analysis showed a reduced receptor–mediated en-
docytosis in RapDTubule and RapRicDTubule mice in comparison
2 Journal of the American Society of Nephrology J Am Soc Nephrol 28: ccc–ccc, 2016
BASIC RESEARCH www.jasn.org
Figure 1. Proximal tubular deletion of mTORC1 leads to a Fanconi like syndrome. (A–C) Schematic of recombination strategy and site
of inducible Pax8rtTA 3 TetOCre–mediated (A) Raptor, (B) Rictor, and (C) double knockout within the tubular system. (D–F) Dem-
onstration of knockout efﬁcacy by Western blot of (D) RAPTOR and downstream target p-S6P/S6P in RapDTubule, (E) RICTOR and the
downstream target p-NDRG1/NDRG1 in RicDTubule, and (F) RAPTOR and RICTOR and downstream targets p-S6P/S6P and p-NDRG1/
NDRG1 in RapRicDTubule. (G) Urinary glucose (gluc) and phosphate (PO4
32) excretions in RapRicDTubule were increased. (H and I)
Coomassie staining of SDS-PAGE prepared from urine samples loaded after normalization to urinary creatinine concentration from (H)
RapDTubule and (I) RapRicDTubule. (J) Urinary albumin excretion of RapDTubule and RapRicDTubule. (K) Urinary neutral amino acid excretion
of RapDTubule, RicDTubule, and RapRicDTubule. ACR, albumin-creatinine-ratio; Con, control; crea, creatinine. *P value versus control
,0.05; **P value versus control ,0.01.
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with respective control animals (Figure 2B). Introducing anmT/
mG reporter allele into RapDTubule animals revealed very few
events of a mosaic Cre expression in PT cells. However, these
few mosaic areas allowed a detailed cell to cell analysis of endo-
cytosis. Cre–positive, Raptor–deﬁcient cells in comparison with
Cre–negative, Raptor–positive cells showed a highly impaired
receptor–mediated endocytosis as identiﬁed by reduced uptake
of Alexa555 lactoglobulin (Figure 2C). To quantify receptor–
mediated endocytotic ﬂux, ﬂuorimetric measurements of
endocytosed Alexa555 lactoglobulin in tissue homogenates
were performed. Reduced endocytotic ﬂuxes were observed in
RapDTubule and RapRicDTubule animals, with no difference in
RicDTubule mice (Figure 2D). To examine intracellular trafﬁck-
ing, we stained for cellular endogenous albumin distribution.
RapDTubule mice and even more RapRicDTubule mice showed
an accumulation of endogenous albumin with increases in ves-
icle size and number (Figure 2E). This is in agreement with
reduced intracellular trafﬁcking and protein processing. Be-
cause MEGALIN and CUBILIN are the main receptors for
PT endocytosis, their expression pattern and abundance were
analyzed. Immunoblotting and staining analyses revealed no
change between groups in either subcellular localization or
expression level (Supplemental Figure 3).
Taken together, these data show that mTOR function is
required for PT endocytosis and intracellular trafﬁcking,
whereas the abundance of the apical scavenger receptors
seemed unaffected. To analyze whether duration of kinase
deletion could play a role, we assessed histologic alterations in
Figure 2. Deletion of mTORC1 leads to a reduced ﬂuid-phase as well as receptor-mediated endocytosis and blocks intracellular
trafﬁcking. (A) Fluid-phase and (B) receptor-mediated endocytosis is shown by the uptake of horseradish peroxidase or Alexa555-
coupled lactoglobulin (red stain), respectively, injected 5 minutes before perfusion-ﬁxation. Reduced uptake is found in RapDTubule and
RapRicDTubule. (C) Cell by cell analysis of receptor-mediated endocytosis in RapDTubule 3 mT/mG mice. Cre-positive cells (green stain)
show reduced endocytic uptake of Alexa555-coupled lactoglobulin (red vesicular staining) in comparison with Cre-deﬁcient cells. (D)
Quantiﬁcation of Alexa555-coupled lactoglobulin of RapDTubule, RicDTubule, and RapRicDTubule normalized to the respective control mice.
Signiﬁcantly reduced uptake is shown for RapDTubule and RapRicDTubule animals. (E) Assessment of endogenous albumin content in
RapDTubule, RicDTubule, and RapRicDTubule. Note the increased number and size of albumin-containing vesicles. In immunoﬂuorescence
images, kidney sections were counterstained with Alexa647 phalloidin (blue stain) to mark actin ﬁlaments of the BBM. Con, control.
Scale bar, 20 mm. **P,0.01.
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RapDTubule and RapRicDTubule mice 3 months after induction.
In RapDTubule and RapRicDTubule (much stronger) animals, the
renal cortex was reduced, which was mainly caused by shrink-
age of the convoluted part of the PT (Supplemental Figure
4A). MEGALIN and CUBILIN expression levels remained un-
altered in RapDTubule but were decreased in RapRicDTubule
(Supplemental Figure 4, B and C). We next analyzed the ex-
pression pattern of the Na+/K+-ATPase (NKA), a basolateral
protein being expressed in a polarized fashion. Interestingly,
in RapDTubule and RapRicDTubule animals 3 months postinduc-
tion, apical NKA–containing vesicles were observed, showing
an apical mis-sorting of this protein. In addition, we
discerned a striking reduction of basolateral NKA expression
in RapRicDTubule animals. These data show that apical scaven-
ger receptor expression remained intact in RapDTubule mice,
although signs of epithelial depolarization could be detected,
whereas PT cells dedifferentiated in RapRicDTubule animals,
leading to reduced MEGALIN and CUBILIN expression.
Loss of mTOR Results in Altered Apical Plasma
Membrane Topology with a Reduced Reabsorption
Surface In Vivo
Light and electron microscopy analyses were performed to
correlate reduced PT function with changes in morphology.
Periodic acid–Schiff staining on parafﬁn sections revealed re-
duced brush border membrane (BBM) microvilli in all trans-
genic knockout mice, which was most evident in RapDTubule
and RapRicDTubule compared with control animals (Figure
3A). The overall gross morphology, however, remained un-
changed as shown in methylene blue–stained semithin sec-
tions (Figure 3B). Subcellular electron microscopy analysis of
PT S1 segments in RapDTubule and RapRicDTubule mice showed
reduced microvilli length and endosomal vesicle formation
compared with control animals as well as reduced numbers
of mitochondria in RapRicDTubule animals (Figure 3C, Supple-
mental Table 2). Additionally, largely inﬂated early and late
endosomes and Golgi cisternae were observed in RapDTubule
and RapRicDTubule mice.
Reduced Endocytosis Is Caused by Diminished
Formation of Clathrin-Coated Vesicles
To gain additional mechanistic insights, we analyzed endocy-
tosis in the well established opossum kidney proximal tu-
bule cell (OKC) line.17 OKCs were incubated with 100 nM
rapamycin (mTORC1 inhibitor), 100 nM PP242 (mTORC1+2
inhibitor), or 250 nM torin (mTORC1+2 inhibitor) for 3 days
or 3 or 10 mM PF-4708671 (S6K1 inhibitor) overnight before
endocytosis assays followed by ﬂow cytometric analysis of en-
docytosed Alexa647 albumin. Similar to our in vivo ﬁndings,
treatment with rapamycin, PF-4708671, PP242, or torin led
to a strong reduction of endocytosed Alexa647 albumin (Sup-
plemental Figure 5A). Increasing concentrations of rapamycin
reduced the endocytosis rate in a concentration-dependent
manner (Supplemental Figure 5B). To allow speciﬁc differen-
tiation between mTORC1 and mTORC2 signaling, we
performed shRNA–mediated viral knockdown of the main
mTORC1–dependent translational regulator S6K1, RICTOR,
or both genes together. Compared with mock transduction, all
virally transduced OKCs showed a signiﬁcant reduction in
their endocytosis rate, with the strongest decrease observed
in S6K1 or S6K1/RICTOR shRNA knockdown (Supplemental
Figure 5, C and D). mTORC1 andmTORC2 signaling showed
no inﬂuence on lysosomal pH and enzyme activity (Supple-
mental Figure 5E). In addition, enzymatic activity of galac-
tosidase, mannosidase, and a-glucuronidase remained
unchanged on viral knockdown of S6K1, RICTOR, or S6K1/
RICTOR compared with mock transduction (data not
shown). Formation of clathrin-coated vesicles as a readout
of membrane formation was reduced in S6K1 and double
shRNA–transduced OKCs (Supplemental Figure 5, F and G).
This may affect the formation of endocytotic vesicles as de-
scribed in the electron microscopic analysis of the transgenic
mouse models.
Proteomic and Phosphoproteomic Analyses of Kidney
Cortex Identify a Putative mTOR–Dependent
Transport Regulatory Protein Network
To further elucidate the molecular causes for the observed
reduction in PT transport function, we performed detailed
proteomic and phosphoproteomic analyses of renal cortex in
RapDTubule and respective control animals. Although overall
differences between control and RapDTubule animals were
rather subtle (Figure 4A), several amino acid transporters,
such as SLC6A19 (B0AT1), SLC7A7 (y+LAT1), and SLC3A2
(4F2hc), as well as proteins related to polarity and endocytosis
(e.g., DOCK8, Bcl2-like 1 [BCL-xL], Ras–related protein
Rab-10 [RAB10], and sorting nexin 8 [SNX8]) were reduced
(Figure 4B, Supplemental Table 3). Making use of the mosaic
expression pattern of RAPTOR-deﬁcient cells in RapDTubule,
we could conﬁrm by immunohistochemistry the reduced ex-
pression of B0AT1, y+LAT1, 4F2hc, DOCK8, and BCL-xL in
RAPTOR-deﬁcient cells in comparison with wild-type cells
(Figure 5, A–E). This was corroborated by Western blot anal-
ysis from isolated cortical kidney membranes (Figure 5F),
which conﬁrmed our proteomic ﬁndings.
Interestingly, BBM-bound enzymes, such as 59 nucleotid-
ase, glutamylaminopeptidase, and angiotensin-converting
enzyme 2, or mitochondrial proteins, such as cytochrome
P450 4A12A and cytochrome b-c1 complex subunit 8, were
upregulated, likely in a compensatory fashion in RapDTubulemice
(Figure 4B). We carried out gene ontology enrichment of the
changed protein population compared with the unchanged
protein population. Several nutrient transport pathways in
the PT were again found to be signiﬁcantly downregulated in
RapDTubule mice (Figure 4C). Small ﬁltered proteins taken up
by the PT (e.g., transthyretin, angiotensinogen, retinol binding
protein, vitamin D binding protein, and b2-microglobulin)
were enriched in the renal cortexes of RapDTubule animals com-
pared with controls (Figure 4D, Supplemental Table 3). Over-
all analysis of phosphosites again only showed subtle
J Am Soc Nephrol 28: ccc–ccc, 2016 mTOR Regulates PT Transport 5
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differences between the two genotypes (Figure 4E). However,
detailed analysis revealed reduced phosphorylation of several
transport proteins, especially amino acid transporter SLC7A9
(b0,+AT) and the sodium–dependent glucose transporter 2
(SGLT2; SLC5A2) providing additional potential molecular ex-
planation for the observed aminoaciduria and glucosuria (Fig-
ure 4F, Supplemental Table 4). Additionally, an up to eight
times reduction on three so far unknown phosphosites of the
Na+/HCO32 cotransporter (NBC1; T3, S232, and S1060) and
the ArfGEF GBF-1 (S179) were identiﬁed. To further evaluate
the functional importance of the later protein, we used the
Drosophila melanogaster system to perform an siRNA knock-
down in nephrocytes, the highly endocytotic storage kidney
cells of the ﬂy. Interestingly, knockdown of GBF-1 led to a
marked reduction in endogenous uptake of a ﬂuorescently
labeled marker protein (Figure 5G). In line, TEM showed a
phenotype consistent with a severely deranged endocytotic
machinery (Figure 5H).
In contrast, several mTORC2 targets, especially NDRG1,
were found to have an increased phosphorylation status (T328
andS342). Similar to the gene ontology enrichment analysis on
protein level, transmembrane transport activity as well as
Figure 3. mTOR deletion leads to ultrastructural alterations in PT cells. (A) Periodic acid–Schiff–stained sections of control (Con), RapDTubule,
RicDTubule, and RapRicDTubule showing reduced BBM length in mutants compared with control mice. (B) Semithin sections counterstained
with methylene blue from Con, RapDTubule, RicDTubule, and RapRicDTubule showing intact morphology of epithelial cells. (C) Electron mi-
croscopy images of Con, RapDTubule, RicDTubule, and RapRicDTubule showing reduced number and length of BBM microvilli and reduced
number of clathrin-coated vesicles as well as recycling endosomes in otherwise normal cellular structures in mutant compared with control
animals. Note the increase in early and late endosomes in mutant cells compared with Con in C. Scale bar, 20 mm and 2 mm.
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membrane components were most signiﬁcantly regulated
(Figure 4G). Interestingly, when integrating both proteomic
and phosphoproteomic datasets, it became evident that
changes in phosphorylation were not a mere consequence of
changes in protein abundance (Figure 4H). We ﬁnally analyzed
phosphomotifs being up- or downregulated. Downregulated
phosphorylation sites mainly contained a proline-directedmo-
tif ([S/T]–P), a motif consistent with phosphorylation by
mTOR but also, other proline–directed kinases (Figure 4I).18
Phosphorylation sites containing the AGC Kinase motif RxxS
were increased.
DISCUSSION
Although the pleiotropic functions of mTOR kinases have
recently become evident, very little is known about their
complex role in regulating epithelial protein transport and
endocytosis. Interestingly, registry datasets after renal trans-
plantation document reduced serum potassium and phos-
phorus levels in sirolimus-treated patients,19–21 pointing
toward an mTOR regulatory function for electrolyte transport
and homeostasis. Using inducible, gene–targeted, speciﬁc dis-
ruption of mTORC1, mTORC2, or both mTOR complexes in
Figure 4. Proteomic analyses of RapDTubule mice shows reduced abundance and phosphorylation of both tubular transport proteins and
regulators of endocytosis. (A) Hierarchical clustering of identiﬁed proteins and the samples on the basis of the protein LFQ intensities.
(B) Volcano plot of the proteomic analysis of RapDTubule mice compared with the control mice. Proteins beyond the curved lines were
considered to be signiﬁcantly changed (red, increased; blue, decreased). (C) Analysis of over–represented gene ontology (GO) terms in
the decreased and increased protein populations compared with the unchanged protein population (Fisher exact test; size of the
squares represents number of condensed terms). (D) Cumulative histogram of all quantiﬁed proteins (black) and proteins with the
uniprot keyword secreted (red). Subgroups of this protein population with small molecular weight are depicted in magenta. (E) Hi-
erarchical clustering of identiﬁed phosphorylation site intensity. (F) Volcano plot of the intensity of phosphorylation sites in the
RapDTubule mice compared with the control mice. Phosphorylation sites beyond the curved lines were considered to be signiﬁcantly
changed. (G) Analysis of over–represented GO terms in the signiﬁcantly changed phosphorylation site population compared with the
unchanged population (Fisher exact test). (H) Comparison of logarithmized expression ratios (RapDTubule to control) for proteins and
their respective phosphorylation sites. Density is color coded. (I) Position-weighted matrix of phosphorylation motifs present in the
increased and decreased phosphorylation site populations. GOCC, go-term cellular component; GOMF: go-term molecular function;
LFQ, label free quantiﬁcation; TTA: trans-tubular-absorption.
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Figure 5. Reduced expression of transport proteins and regulators of endocytosis can be found in proximal tubular cells of RapDTubule
mice. For better illustration, RapDTubule 3 mT/mG mice were used for analysis of expression levels of various proteins by cell to cell
analysis of Cre-positive (green stain) compared with wild-type cells. (A) B0AT1, (B) y+Lat1, (D) DOCK8, and (E) BCL-xL showed strongly
reduced expression levels in Cre-positive cells compared with wild-type cells. Borders between cells types are marked with white bars.
(C) In the case of 4F2hc, Alexa555 lactoglobulin was used to distinguish between Cre-positive cells and wild-type cells, and borders
are marked by white bars. Cre-positive cells with reduced uptake of Alexa555 lactoglobulin also showed reduced basolateral ex-
pression level of 4F2hc. (F) Western blots of B0AT1, y+Lat1, 4F2hc, DOCK8, and BCL-xL from control (Con) and Rap
DTubule (left panel)
and densitometric evaluation (right panel) conﬁrm immunohistochemical results. (G) RNAi-mediated knockdown of Gbf-1 (CG8487;
gartenzwerg) was generated in Drosophila, and RFP-ANP (red) ﬂuorescence uptake was measured in nephrocytes (green). Quantiﬁ-
cation is presented in right panel. (H and I) Transmission electron microscopy images of Drosophila from (H) control and (I) Gbf-1
knockdown are shown. In comparison with control nephrocytes with a proper formation of the endocytotic machinery, Gbf-1
knockdown shows loss of clathrin vesicles and early, late, and recycling endolysomes, whereas the formation of aberrant vesicular
structures is increased. Scale bar, 20 mm in A–E; 2 mm in H; 0.2 mm in H, inset; 0.5 mm in I; 0.25 mm in I, inset. *P value versus control
,0.05; **P value versus control ,0.01. RFP-ANP, red-ﬂuorescent-protein atrial natriuretic peptide; RNAi, RNA interference.
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PT cells, we can now delineate the inﬂuence of mTOR signal-
ing on PT physiology, protein transport, and endocytosis with
unprecedented detail (Figure 6). In fact, disruption of
mTORC1 signaling leads to a Fanconi-like syndrome, which
presents with phosphaturia, glucosuria, aminoaciduria, and
LMW proteinuria. On a molecular level, both ﬂuid-phase
and receptor–mediated endocytosis are impaired and coincide
with an altered BBM length and vesicle formation in the PT.
mTOR Regulates the Endocytosis Machinery in PT
Epithelial Cells
Tubular albuminuria and LMW proteinuria are well estab-
lished features of Fanconi syndrome and known to occur in
patients treated with mTOR inhibitors after renal transplan-
tation.22,23 Our study now highlights a signiﬁcantly reduced
tubular internalization in RapDTubule and RapRicDTubule mice,
which was consistent with endocytosis assays performed in
vitro. Surprisingly, MEGALIN and CUBILIN, which are the
main renal scavenger receptors for ﬁltered urinary proteins,
were not directly regulated by mTOR in our functional studies
(short–term follow-up after inducedmTORdeletion).9 This is
in contrast to recently published data, in which long–term (6
months) rapamycin treatment was shown to lead to a reduced
MEGALIN expression in mice.24 However, it has been recog-
nized that long-term administration of rapamycin in high
doses additionally inhibits mTORC2 and exerts cytotoxic ef-
fects.25 In agreement, long–term follow-up studies (3months)
in our double–knockout RapRicDTubulemice showed a reduced
MEGALIN expression, whereas RapDTubule mice maintained a
stable MEGALIN expression. Additionally, we detected a
strong reduction in the overall renal cortex volume because
of shortening of the S1/2 segment in RapDTubule mice, and it
was more pronounced in RapRicDTubule mice, conﬁrming the
importance of mTOR signaling for general cellular programs,
such as cell growth, proliferation, and metabolism.
In addition to the impairment of the initiating steps of
endocytosis, we also observed a disturbed endocytic trafﬁcking
as indicated by increased amounts of endocytosed albumin in
RapDTubule and RapRicDTubule animals. Furthermore, proteo-
mic analysis of RapDTubule identiﬁed increased intracel-
lular amounts of LMW proteins, such as angiotensinogen,
retinol binding protein, vitamin D binding protein, and b2-
microglobulin. These proteins are physiologically endocy-
tosed by PT cells and further processed for degradation or
transcytosis.26 Intracellular trafﬁcking is a prerequisite for
both processes, and its disturbances may, hence, lead to in-
tracellular accumulations as observed in our animal models
(Figure 2).
Proteomic data of RapDTubule kidney cortex did identify re-
duced expression or phosphorylation level of interesting can-
didate proteins, such as BCL-xL, GBF-1, SNX8, RAB10, and
DOCK8, to explain the reduced endocytosis rate, altered api-
cal membrane differentiation, and impaired intracellular traf-
ﬁcking. BCL-xL is an antiapoptotic protein with a role in the
regulation of membrane dynamics and endocytosis.27
DOCK8, a member of the evolutionarily conserved DOCK
family proteins,28 was shown to bind to nucleotide-free
CDC42 to mediate the GTP-GDP exchange reaction. Thereby,
CDC42 is spatially activated at the plasmamembrane,29 where
it plays a crucial role in apical differentiation and BBM for-
mation.30 Another GEF, the ArfGEF GBF-1, presented a
strongly diminished phosphorylation status in RapDTubule
animals. Arf-GEFs are nucleotide exchange factors for Arf
GTPases, which have diverse functions in vesicle coat forma-
tion and vesicle-cytoskeleton interactions.31 SNX8 was found
to localize at early endosomes, and its knockdown was shown
to affect intracellular vesicle trafﬁcking.32 RAB10 has been
localized to many organelles, such as endoplasmic reticulum
(ER), Golgi, early endosomes, and recycling endosomes, and
mediates membrane trafﬁcking within the cell partly by reg-
ulating endosomal phosphatidylinositol-4,5-bisphosphate
levels.33,34 Together, these data reveal a novel theme of mTOR
function by regulating a series of proteins being speciﬁcally in-
volved in endocytosis and vesicle transport.
mTOR Regulates Speciﬁc Apical Tubular Transport
Proteins
Many BBM transporters were affected by Raptor deletion, re-
sulting in a Fanconi-like syndrome. SGLT2 (SLC5A2) is the
main apical glucose transporter in the PT S1 and S2 segments,
with an exclusive localization to the BBM.35 The transporter
activity is decisively regulated by phosphorylation.36 Phos-
phoproteomics of RapDTubule mice pointed to a reduced phos-
phorylation of SGLT2 at S623 in comparison with control
animals. This residue is a highly conserved phosphosite
between species, including human SGLT2 (S624).36 Aug-
mented phosphorylation at this site was shown to enhance
glucose transport by increasing membrane insertion of
SGLT2.36 Loss of mTORC1-induced phosphorylation at
S623 could, hence, contribute to glucosuria in RapDTubule
and RapRicDTubule animals.
RapDTubule and even more so, RapRicDTubule mice dis-
played a highly increased excretion of neutral, basic, and
acidic amino acids compared with control mice (Figure 1,
Supplemental Figure 2). Proteomic and phosphoproteomic
analyses of RapDTubule animals identiﬁed reduced expression
or phosphorylation states of many amino acid transporters
known to be highly expressed in the PT.37 Among these,
SLC6A19 (B0AT1), SLC7A7 (y+LAT1), and SLC3A2 (4F2hc)
had reduced expression levels, whereas diminished phosphor-
ylation was found in SLC7A9 (b0,+AT) at position S15 and S18.
B0AT1 mediates neutral amino acid transport from the lumi-
nal compartment into the cellular lumen.37 b0,+AT, a member
of the heterodimeric amino acid transporter family, is the light
subunit of SLC3A1 (rBAT), facilitating dibasic amino acid and
cysteine transport into the cell. y+LAT1, another member of
the heterodimeric amino acid transporter family, is exclusively
expressed in the PT, whereas its companion 4F2hc is ubiqui-
tously expressed. y+LAT1 and 4F2hc both assemble to
form a heterodimeric amino acid transporter localizing to
J Am Soc Nephrol 28: ccc–ccc, 2016 mTOR Regulates PT Transport 9
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the basolateral membrane of the PT predominantly in the S1
segment. Interestingly, this transporter mediates efﬂux of di-
basic amino acids in exchange for neutral amino acids and
sodium together with b0,+AT and its subunit rBAT. Loss of
function mutations result in an inefﬁcient urea cycle with
consecutive hyperammonemia,37 which could, at least in
part, explain increased urea values of RapRicDTubule animals.
Phosphoproteomic analysis of RapDTubule renal cortexes
revealed a strong reduction in the phosphorylation level of
three phosphorylation sites on SLC4A4 (NBC1). Inactivating
mutations of this gene were reported to lead to renal PT aci-
dosis, another commonly observed feature of Fanconi syn-
drome.6 Whether the identiﬁed phosphosites inﬂuence
NBC1 transport needs additional determination on a molec-
ular level.38,39 In accordance with other reports using rapamy-
cin, despite similar expression of the major PT phosphate
transporters (NaPi-IIa, NaPi-IIc, and Pit-2), we detected
phosphaturia in RapDTubule and RapRicDTubule animals.40,41
Inﬂuence of mTORC1 on so far unidentiﬁed interaction part-
ners might be responsible for this enigmatic ﬁnding.
In summary, mTORC1 deletion leads to a generalized PT
dysfunction, mimicking the clinical diagnosis of Fanconi
syndrome (Figure 6). Our in-depth analysis reveals probable
molecular pathways being affected in an organ-speciﬁc fash-
ion. Additionally, we have identiﬁed a novel main kinase reg-
ulator of PT function, opening new avenues for subsequent
studies to unravel the kinase networks governing PT transport
in health and disease.
CONCISE METHODS
Animals and Treatments
All animal experiments were conducted according to the National
Institutes of Health guide for the care and use of laboratory animals as
well as the German law for the welfare of animals, and they were
approved by local authorities (G-13/07, M-9/11, and M-4/13). Mice
were housed in an SPF facility with free access to chow andwater and a
12-hour day-night cycle. Breeding and genotyping were done
according to standard procedures. Raptorﬂ/ﬂ and Rictorﬂ/ﬂ mice
have been described previously42 and were crossed to Pax8rtTA43
and TetOCre44 animals. At 5 weeks of age, inducible animals and
respective controls (lacking either TetOCre or Pax8rtTA) received
doxycycline hydrochloride (Fagron, Barsbuettel, Germany) via the
Figure 6. Putative mTORC1–dependent regulation of proximal tubular transport and endocytosis. (A) mTORC1 seems to regulate
apical and basolateral PT transport proteins. mTORC1 could directly phosphorylates SGLT2 and NBC1 to increase reabsorption of
glucose and sodium and excretion of sodium and bicarbonate. mTORC1 might positively inﬂuence the expression level of the amino
acid transporter B0AT1 and y+LAT-4F2hc and the phosphorylation status of b0,+AT1-rBAT to reabsorb ﬁltered amino acids and secrete
them into the bloodstream. (B) mTORC1 could regulate PT endocytosis, membrane biogenesis, vesicle trafﬁcking, and cell polarity.
mTORC1 likely controls apical membrane biogenesis and cell polarity by affecting expression level of DOCK8, apical clathrin–coated
pit and vesicle formation, and endocytosis by affecting the expression levels of BCL-xL, SNX8, and RAB10 and phosphorylation level of
GBF-1. Also, it controls proper endoplasmic reticulum (ER) function and Golgi integrity again by inﬂuencing the expressions and
phosphorylation levels of RAB10 and GBF-1, respectively.
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drinking water (2 mg/ml with 5% sucrose protected from light) for a
total of 14 days. To estimate recombination efﬁcacy and identify cellular
mosaicisms, we crossed the reporter mouse strain mT/mG with some
Raptorﬂ/ﬂ 3 Pax8rtTA 3 TetOCre mice (Supplemental Material).45
Presentation of Data and Statistical Analyses
Quantitative data are presented as means6SEM. Statistical compar-
isons were performed using the GraphPad Prism Software Package 6
(GraphPad Software, La Jolla, CA). For statistical comparison, the
Mann–Whitney U test, the two–tailed t test, and where appropriate,
ANOVA were used. P values of ,0.05 were considered statistically
signiﬁcant.
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